Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Liabilities and Shareholders Equity (2016 - 2026)

Orthofix Medical has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $886.6 million for Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 7.71% year-over-year to $886.6 million, compared with a TTM value of $3.4 billion through Mar 2026, down 1.71%, and an annual FY2025 reading of $850.6 million, down 4.77% over the prior year.
  • Liabilities and Shareholders Equity came in at $886.6 million for Q1 2026, up from $850.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $925.3 million in Q4 2023 to a low of $449.7 million in Q3 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $867.9 million (2024), compared with a mean of $780.0 million.
  • The sharpest move saw Liabilities and Shareholders Equity decreased 10.14% in 2022, then soared 101.76% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $458.6 million in 2022, then soared by 101.76% to $925.3 million in 2023, then dropped by 3.46% to $893.3 million in 2024, then decreased by 4.77% to $850.6 million in 2025, then increased by 4.23% to $886.6 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Liabilities and Shareholders Equity are $886.6 million (Q1 2026), $850.6 million (Q4 2025), and $832.6 million (Q3 2025).